Hrt Financial LP Aspira Women'S Health Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.4 - $1.09 $44,167 - $120,355	110,418 Added 984.47%	121,634 $71,000
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $40,526 - $83,355	-46,053 Reduced 80.42%	11,216 $11,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $3.43 $133,483 - $280,889	-81,892 Reduced 58.85%	57,269 $101,000
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $3,209 - $5,512	1,006 Added 0.73%	139,161 $452,000
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $660,380 - $944,980	138,155 New	138,155 $776,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.